Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
| Year | Award Type | Project # |
RFA # |
PI/Project Leader | Institution | Title | Status |
|---|---|---|---|---|---|---|---|
| 2016 | R43 | CA203671 | PAR-13-327 | OUELLETTE, STEVEN BRADLEY | KINASENSE, LLC | DEVELOPMENT OF AN ASSAY PLATFORM FOR MEASURING ENDOGENOUS KINASE ACTIVITY | Complete |
| 2015 | R43 | CA199142 | PAR-13-327 | ORBAI, LUCIAN | CELL DATA SCIENCES, INC. | RESCUING NUCLEIC ACIDS FROM FORMALIN DAMAGE IN CANCER SPECIMENS | Complete |
| 2016 | R43 | CA203675 | PAR-13-327 | KLUGE, JONATHAN AUGUST | VAXESS TECHNOLOGIES, INC. | SILK-BASED BLOOD SAMPLE STABILIZATION FOR PROSTATE CANCER DIAGNOSTICS | Complete |
| 2015 | R43 | CA199152 | PAR-13-327 | EASTBURN, DENNIS J | MISSION BIO, INC. | MOLECULAR CHARACTERIZATION OF CIRCULATING TUMOR CELLS WITH PCR-ACTIVATED CELL SORTING | Complete |
| 2016 | R43 | CA203629 | PAR-13-327 | GUNDERSON, KEVIN L | ENCODIA, INC. | Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer | Complete |
| 2015 | R43 | CA199211 | PAR-13-327 | GAU, VINCENT JEN-JR | GENEFLUIDICS, INC. | PROMOTE HPV SCREENING RATE WITH A NON-INVASIVE HPV POC CARTRIDGE | Complete |
| 2016 | R43 | CA203647 | PAR-13-327 | LIM, MARK | AMBERGEN, INC | Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays | Complete |
| 2016 | R43 | CA203681 | PAR-13-327 | KING, JEFFREY S | VIROGENOMICS BIODEVELOPMENT, INC. | Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia | Complete |
| 2016 | R44 | CA199194 | PAR-13-327 | KARSTEN, STANISLAV | NEUROINDX INC. | Automated Platform for Fixed Tissue Microdissection | Complete |
| 2016 | R44 | CA187852 | PAR-13-327 | JOHNSON, DAVID SCOTT | GIGAGEN, INC. | Next-Generation Antibody Discovery and Development Technology | Complete |
| 2014 | R43 | CA187852 | PAR-13-327 | JOHNSON, DAVID SCOTT | GIGAGEN, INC. | B CELL REPERTOIRE MOLECULAR PLATFORM FOR ANTIBODY DRUG DISCOVERY | Complete |
| 2014 | R43 | CA188154 | PAR-13-327 | FELLMANN, CHRISTOF | MIRIMUS, INC. | RNA INTERFERENCE - GENETICALLY ENGINEERED MOUSE MODELS(RNAI-GEMMS): A NOVEL APPRO | Complete |
| 2014 | R44 | CA161965 | PAR-13-327 | LIM, MARK | AMBERGEN, INC | GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS | Complete |
| 2017 | R43 | CA214386 | PAR-13-327 | PEYTAVI, REGIS | BLUENOVO BIOSYSTEMS, INC. | Detection of Methylation and Translocation Events by Novel Sequencing Technology | Complete |
| 2017 | R44 | CA188154 | PAR-13-327 | PREMSRIRUT, PREM KHOVABUTR | MIRIMUS, INC. | Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research | Complete |
| 2015 | R43 | CA187787 | PAR-13-327 | SELIGMANN, BRUCE E. | BIOSPYDER TECHNOLOGIES, INC. | IN SITU RNA-FISH WITH LOCALIZED PROFILING BY SEQUENCING FROM FFPE | Complete |
| 2020 | R43 | CA243757 | PAR-18-303 | ERVIN, ERIC | ELECTRONIC BIOSCIENCES, INC. | N6-Methyl-2-O-Methyladenosine Sequencing | Active |
| 2020 | R44 | CA247353 | PAR-18-303 | FRIEDA, KIRSTEN | SPATIAL GENOMICS, INC. | Spatial and single cell analysis of tumor microenvironment by seqFISH+ | Active |
| 2020 | R43 | CA250805 | PAR-18-303 | WANG, SHA | VIVID TECHNOLOGIES | New specific and rapid assay for in situ apoptosis labeling for cancer studies | Active |
| 2021 | R44 | CA261523 | PAR-18-303 | HUNG, PAUL JU-SUNG | COMBINATI, INC. | Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring | Active |
| 2020 | R44 | CA243990 | PAR-18-303 | GURARD-LEVIN, ZACHARY | SAMDI TECH, INC. | Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities | Active |
| 2020 | R44 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues | Active |
| 2020 | R43 | CA250885 | PAR-18-303 | REDER, NICHOLAS | LIGHTSPEED MICROSCOPY, INC. | Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies | Active |
| 2018 | R43 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | Active |
| 2018 | R43 | CA236101 | PAR-18-303 | LEE, LY JAMES | NANOMATERIAL INNOVATION, LTD | Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis | Complete |
| 2018 | R43 | CA236142 | PAR-18-303 | SCHOETTLE, LOUIS | GEMNEO BIOSCIENCE, INC. | Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes | Complete |
| 2019 | R43 | CA236103 | PAR-18-303 | KHODAVERDIAN, VARANDT Y. | NUPROBE USA, INC. | Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing | Complete |
| 2020 | R43 | CA236167 | PAR-18-303 | WARREN, CHRISTOPHER L | PROTEOVISTA, LLC | Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations | Active |
| 2019 | R43 | CA236167 | PAR-18-303 | WARREN, CHRISTOPHER L | PROTEOVISTA, LLC | Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations | NCE |
| 2019 | R43 | CA236177 | PAR-18-303 | KASOJI, SANDEEP | TRIANGLE BIOTECHNOLOGY, INC. | SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples | Complete |
| 2020 | R44 | CA250672 | PAR-18-303 | WINTERS, IAN PAUL | D2G ONCOLOGY, INC. | Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform | Active |
| 2019 | R43 | CA239967 | PAR-18-303 | BROWN, MARK T | CLAREMONT BIOSOLUTIONS, LLC | Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis | Complete |
| 1999 | R41 | CA081825 | PAR-98-066 | MACH, ROBERT H | ANASAZI BIOMEDICAL RESEARCH, INC. | SIGMA 1 RECEPTOR PROBES FOR IMAGING TUMOR PROLIFERATION | Complete |
| 1999 | R43 | CA081835 | PAR-98-066 | MOSTERT, MICHAEL J | ECHELON BIOSCIENCES, INC. | PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS | Complete |
| 1999 | R43 | CA081860 | PAR-98-066 | CHANG, HWAI W | STRATAGENE | GENETIC SELECTION FOR PROTEASES AND THEIR SUBSTRATES | Complete |
| 2000 | R41 | CA083369 | PAR-98-066 | SWENBERG, JAMES A | ENO RIVER LABS, LLC | ULTRASENSITIVE METHODS FOR HUMAN DNA ADDUCT QUANTITATION | Complete |
| 1999 | R43 | CA081870 | PAR-98-066 | MILLER, JEFFREY E. | IVS TECHNOLOGIES, LLC | NEW METHOD FOR THE SYNTHESIS OF CDNA FROM CANCER CELLS | Complete |
| 2000 | R41 | CA084688 | PAR-98-066 | SKIPPER, PAUL L | NEWTON SCIENTIFIC, INC. | TRITIUM AMS ANALYSIS OF CANCER BIOMARKERS | Complete |
| 1999 | R43 | CA081890 | PAR-98-066 | NERI, BRUCE P | THIRD WAVE TECHNOLOGIES, INC. | SPECIFIC AND SENSITIVE MUTATION AND SNP DETECTION | Complete |
| 2000 | R41 | CA084693 | PAR-98-066 | LIFSHITZ, NADIA | BIOPHOTONICS CORPORATION | MONOLITHIC MULTI-CAPILLARY ARRAYS TO SEQUENCE DNA | Complete |
| 1999 | R43 | CA081891 | PAR-98-066 | WEAVER, DANIEL C | GENOMICA CORPORATION | ANALYZING GENE EXPRESSION FOR CANCER GENE DISCOVERY | Complete |
| 1999 | R43 | CA081903 | PAR-98-066 | TS'O, PAUL O. P. | CCC DIAGNOSTICS, LLC | ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD | Complete |
| 1999 | R43 | CA081949 | PAR-98-066 | OLINER, JONATHAN D | AFFYMETRIX, INC. | REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS | Complete |
| 2000 | R43 | CA084678 | PAR-98-066 | BAMDAD, CYNTHIA C. | MINERVA BIOTECHNOLOGIES CORPORATION | RAPID ELECTRONIC DETECTION OF CELL SURFACE PROTEINS | Complete |
| 1999 | R43 | CA081951 | PAR-98-066 | XANTHOPOULOS, KLEANTHIS G | AURORA BIOSCIENCES CORPORATION | ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS | Complete |
| 2001 | R43 | CA084679 | PAR-98-066 | PERLIN, MARK W | CYBERGENETICS CORPORATION | AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY | Complete |
| 2000 | R43 | CA084679 | PAR-98-066 | PERLIN, MARK W | CYBERGENETICS CORPORATION | AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY | Complete |
| 1999 | R43 | CA081952 | PAR-98-066 | CHEE, MARK S. | ILLUMINA, INC. | GENE EXPRESSION ANALYSIS ON RANDOMLY ORDERED DNA ARRAYS | Complete |
| 2000 | R43 | CA084686 | PAR-98-066 | BOGEN, STEVEN A | CYTOLOGIX CORPORATION | INSTRUMENTATION FOR IN SITU ANALYSIS TUMORS | Complete |
| 1999 | R43 | CA081958 | PAR-98-066 | HAGEN, FREDERICK S | ICOGENEX CORPORATION | AFFINITY AND TRANSCRIPTASE TECHNOLOGIES | Complete |